MoonLake Immunotherapeutics
MoonLake Immunotherapeutics
MLTX
Valuace
70
Růst
0
Zdraví
75
Cena
$ 10.65
Dnes
+0.41 (2.51%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.7B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-73%
ROA
-51%
PE
-5
PS
0
Cena 1R
6-63
⌀ Cena
33.72
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda

Profil

MoonLake Immunoterapeutics, biofarmaceutická společnost v klinickém stadiu, se zabývá vývojem terapií. Vyvíjí se Sonelokimab, nová výzkumná Nanobody terapie pro léčbu zánětu. Společnost se podílí na provádění studií fáze II zaměřených na hidradenitis supurativa, psoriatickou artritidu, ankylozující spondylitidu nebo radiograficky axiální spondyloartritidu. Společnost MoonLake Immunotherapeutics byla založena v roce 2021 a sídlí ve švýcarském Zugu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
100
Založení
2020-10-20
Adresa
Dorfstrasse 29
CEO
Jorge Santos da Silva

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021
Total Revenues0.000.000.000.000.000.00
Cost of Revenues2,238.002,616.000.0013.160.000.00
Gross Profit-2,238.00-2,616.000.00-13.160.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.0019.740.00
Cost of Revenues751.00745.00742.000.000.0032.520.000.003.293.29
Gross Profit-751.00-745.00-742.000.000.00-32.520.000.0016.45-3.29
Operating Income TTM 20252024202320222021
R&D Expenses0.000.000.0031,801.8842,048.950.00
Selling General & Admin Expenses0.000.000.0022,321.2223,012.464,570.35
Depreciation & Amortization2,616.002,616.001,384.7313.1612.360.00
Total Operating Expenses242,597.00242,218.00143,091.0854,123.1065,061.424,570.35
Operating Income-244,835.00-244,834.00-143,091.08-54,123.10-65,061.42-4,570.35
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.008,094.507,585.14
Selling General & Admin Expenses0.000.000.000.000.000.000.000.006,931.105,391.61
Depreciation & Amortization751.00745.00742.00378.001,301.2932.52342.00328.003.293.29
Total Operating Expenses64,467.0070,689.0059,956.0047,485.0049,580.3743,079.4930,578.0019,820.0015,025.6012,976.74
Operating Income-65,218.00-71,434.00-60,698.00-47,485.00-49,580.37-43,112.01-30,578.00-19,820.00-15,028.89-12,976.74
Net Income TTM 20252024202320222021
Interest Income0.000.000.000.000.000.00
Interest Expense7,248.007,248.000.000.00-591.730.00
Other Expense15,124.0015,124.0022,128.8810,138.37591.7327.69
IBT-229,710.00-229,710.00-120,962.20-43,984.73-64,469.69-4,542.65
Income Tax Expense611.00611.00282.2094.3936.370.00
Net Income-227,320.00-227,318.00-118,935.52-36,007.26-64,506.05-4,542.65
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.000.000.000.000.000.000.000.000.00
Interest Expense1,995.003,198.002,037.0018.000.000.000.000.000.000.00
Other Expense2,448.00855.004,742.007,079.003,225.817,089.695,898.005,915.007,185.811,386.31
IBT-62,769.00-70,579.00-55,956.00-40,406.00-46,354.56-36,022.32-24,680.00-13,905.00-7,843.08-11,590.43
Income Tax Expense248.00115.0095.00153.0041.1492.1179.0070.0044.3128.92
Net Income-62,427.00-69,729.00-55,220.00-39,944.00-45,604.51-35,390.34-24,267.00-13,673.00-7,437.08-9,426.05
Per Share Data TTM 20252024202320222021
EPS$0.00$0.00$0.00$-0.73$-2.20$-0.38
EPS Diluted$0.00$0.00$0.00$-0.73$-2.20$-1.58
Shares Outstanding64,463.8964,463.8962,870.2449,122.5329,361.3511,930.00
Diluted Shares Outstanding64,463.8964,463.8962,870.2449,122.5329,361.352,875.00
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.12$-0.18
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.12$-0.18
Shares Outstanding64,463.8963,369.9863,282.7363,233.7963,069.8362,896.7862,874.6462,637.2159,914.5953,517.66
Diluted Shares Outstanding64,463.8963,369.9863,282.7363,233.7963,069.8362,896.7862,874.6462,637.2159,914.5953,517.66
Current Assets TTM 20242023202220212020
Cash And Equivalents342,791.14180,426.45451,169.3439,505.638,038.850.00
Short Term Investments177,008.40267,600.9059,838.9032,609.110.000.00
Total Cash & ST Investments519,799.54448,027.35511,008.2472,114.748,038.850.00
Accounts Receivable1,676.812,843.201,056.86217.13148.770.00
Inventory0.000.000.000.001,322.180.00
Other Current Assets15,405.5323,418.302,102.204,179.47126.920.00
Total Current Assets536,881.88474,288.85514,167.3076,511.339,636.720.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents350,736.00306,681.00271,566.00180,426.45375,656.29342,791.14458,441.05451,169.34318,165.81501,787.00
Short Term Investments29,743.00118,402.00208,564.00267,600.90118,268.40177,008.4088,613.7059,838.90177,812.900.00
Total Cash & ST Investments380,479.00425,083.00480,130.00448,027.35493,924.69519,799.54547,054.75511,008.24495,978.71501,787.00
Accounts Receivable4,022.003,409.002,988.002,843.202,407.061,676.811,495.881,056.86720.76619.77
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets26,714.0026,989.0023,146.0023,418.3015,984.4315,405.535,039.342,102.203,310.283,960.38
Total Current Assets411,215.00455,481.00506,264.00474,288.85512,316.18536,881.88553,589.97514,167.30500,009.74506,367.15
Long-Term Assets TTM 20242023202220212020
Net Property, Plant & Equipment3,866.663,644.443,949.35331.9745.740.00
Goodwill0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Long-Term Investments0.000.000.000.00115,042.610.00
Other Long-Term Assets4,129.150.008,423.470.00-115,042.610.00
Total Long-Term Assets7,995.813,644.4412,372.81331.9745.740.00
Total Assets544,877.69477,933.28526,540.1276,843.309,682.450.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment2,533.002,918.003,300.003,644.443,832.583,866.664,208.333,949.35208.94254.05
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.000.000.000.00
Other Long-Term Assets587.001,697.001,698.000.002,064.584,129.156,318.848,423.470.000.00
Total Long-Term Assets3,120.004,615.004,998.003,644.445,897.157,995.8110,527.1712,372.81208.94254.05
Total Assets414,335.00460,096.00511,262.00477,933.28518,213.33544,877.69564,117.14526,540.12500,218.69506,621.20
Current Liabilities TTM 20242023202220212020
Accounts Payable55.998,678.410.00254.971,428.450.00
Short-Term Debt1,321.731,371.961,306.13153.6315,000.000.00
Other Current Liabilities10,341.2511,771.388,291.587,256.854,659.150.00
Current Liabilities12,281.9622,463.869,965.687,665.4521,087.600.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.0014,890.0010,059.008,678.4110,261.654,756.233,085.11553.46824.07270.75
Short-Term Debt1,499.001,550.001,432.001,371.961,752.471,321.731,304.431,306.13156.34316.44
Other Current Liabilities46,869.0010,085.0010,258.0011,771.387,582.415,585.033,669.517,738.126,613.816,547.43
Current Liabilities48,368.0027,361.0023,981.0022,463.8620,081.0212,281.968,910.529,965.6810,308.027,134.63
Long-Term Liabilities TTM 20242023202220212020
Long-Term Debt2,022.281,457.602,499.99128.950.000.00
Capital Leases2,022.282,829.563,806.12282.580.000.00
Def. Tax Liability0.000.000.000.000.000.00
Total Liabilities14,846.1924,542.1413,049.108,076.6021,327.460.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt74,227.0074,217.0074,164.001,457.601,935.712,022.282,357.502,499.9913.0853.02
Capital Leases0.002,386.002,574.002,829.563,688.183,344.013,661.922,499.99169.42211.24
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities123,144.00102,152.0098,681.0024,542.1422,711.6914,846.1911,730.7513,049.1010,576.507,511.24
Total Common Equity TTM 20242023202220212020
Common Stock6.396.396.305.2738.540.00
Retained Earnings-154,598.14-235,592.99-116,657.47-80,650.21-53,643.620.00
Comprehensive Income3,256.914,996.772,357.62350.95-168.180.00
Total Common Equity520,663.74446,825.00495,675.6848,898.30-11,645.010.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock6.006.006.006.396.396.396.396.306.256.25
Retained Earnings-400,486.00-330,757.00-275,537.00-235,592.99-189,988.48-154,598.14-130,331.13-116,657.47-109,220.40-99,794.35
Comprehensive Income278.00520.002,387.004,996.772,833.973,256.912,693.102,357.622,875.2035.12
Total Common Equity288,906.00353,731.00407,520.00446,825.00488,195.33520,663.74542,553.73495,675.68424,933.00489,797.00
Other TTM 20242023202220212020
Total Debt3,344.012,829.563,806.12282.5815,000.000.00
Book Value530,031.50453,391.14513,491.0268,766.70-11,645.010.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt2,285.004,213.005,061.006,566.147,306.329,367.769,832.6617,815.3464,709.199,312.95
Book Value288,906.00353,731.00407,520.00446,825.00488,195.33520,663.74542,553.73495,675.68424,933.00489,797.00
Cash Flow From Operating Activities TTM 20252024202320222021
Net Income-56,997.10-229,099.00-121,244.40-44,079.12-64,506.05-4,542.65
Depreciation & Amortization57.502,616.001,384.7313.1612.360.00
Stock-Based Compensation6,536.6112,898.007,281.607,106.019,654.780.00
Change Working Capital-13,692.1219,878.00-3,783.48-6,217.72-1,427.470.00
Change In Accounts Receivable-1,057.05-2,025.00-1,786.340.000.000.00
Change In Accounts Payable0.000.000.000.000.000.00
Change In Inventories0.000.000.000.000.000.00
Other Non-cash Items3,875.16-2,300.00-225.71399.51372.493,931.58
Cash from Operations-64,433.690.000.00-42,778.17-55,893.90-611.07
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-63,018.00-70,692.00-56,052.00-40,559.00-45,604.51-36,114.70-24,759.00-13,975.00-7,437.08-11,619.35
Depreciation & Amortization751.00745.00742.00378.001,301.29-586.56342.00328.003.293.29
Stock-Based Compensation3,590.003,709.003,309.002,290.000.001,843.061,828.001,677.001,605.511,425.65
Change Working Capital-369.0021,430.00-1,189.00-369.00-3,900.718,282.23-5,320.00-2,845.00-6,537.451,010.78
Change In Accounts Receivable-146.00-612.00-420.00-146.00-436.14-730.20-181.00-439.00-336.11-100.99
Change In Accounts Payable0.000.000.000.000.000.000.000.000.000.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items252.00265.00-1,340.00120.00-269.751,300.3819.00-133.00-16.07-46.99
Cash from Operations0.000.000.000.000.000.000.000.00-12,344.33-9,250.59
Cash Flow From Investing Activities TTM 20252024202320222021
Capital Expenditure-496.40-35.00-519.52-284.63-16.010.00
Acquisitions0.000.000.000.000.000.00
Investments-175,906,865.93-265,374.00-350,278.78-175,732.71-42,226.020.00
Sales of Investment176,328.24468,401.00145,203.00150,833.029,901.440.00
Other Investing Activities175,528,211.390.000.000.000.000.00
Cash from Investing-174,055.800.000.00-25,184.32-32,340.590.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.000.000.00-35.00-175.57-131.950.00-212.00-284.630.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments-59,167.000.00-117,659.00-88,548.00-146,944.09-29,179.69-86,442.00-87,713.00-175,556,978.29-175,732.71
Sales of Investment29,256.0088,403.00205,913.00144,829.00-211.0587,594.05-1,301.0059,121.00117,151.331,357.10
Other Investing Activities0.000.000.000.000.000.000.000.00175,556,978.29-174.38
Cash from Investing0.000.000.000.000.000.000.000.00116,866.70-174,375.61
Cash Flow From Financing Activities TTM 20252024202320222021
Debt Repaid0.000.000.000.00-15,000.000.00
Debt Issued3,132.772,829.56-976.563,523.54282.5815,000.00
Issuance of Common Stock83,709.520.000.00482,454.430.000.00
Repurchase of Common Stock-0.050.00-0.050.000.000.00
Dividends Paid0.000.000.000.000.000.00
Other Financing Activities-4,315.150.000.00-2,752.92134,692.74-58.06
Cash from Financing79,394.320.000.00479,701.51119,692.74-58.06
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued75,726.00-41.00171.0072,766.44-858.62344.18-317.91-35.953,528.44-41.82
Issuance of Common Stock0.000.000.000.000.000.000.000.0031,169.330.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-2,752.920.00
Cash from Financing0.000.000.000.000.000.000.000.0028,416.420.00
Cash position TTM 20252024202320222021
Net Change in Cash-158,995.86154,091.00-270,742.89411.6631,466.78-669.13
Closing Cash Balance342,791.14334,517.00180,426.45451,169.3439,505.63666.79
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-16,219.0044,055.0035,115.0091,140.00-195,229.8432,865.29-115,650.007,272.00133,003.53-183,621.19
Closing Cash Balance334,517.00350,736.00306,681.00271,566.00180,426.45375,656.29342,791.00458,441.00451,169.34318,165.81
Free Cash Flow TTM 20252024202320222021
Free Cash Flow-64,930.09-196,042.00-117,106.78-43,062.80-55,909.91-611.07
Real Free Cash Flow-71,466.70-208,940.00-124,388.38-50,168.81-65,564.69-611.07
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-58,794.00-44,543.00-54,530.00-38,175.00-48,649.24-25,407.54-27,890.00-15,160.00-12,628.96-9,250.59
Real Free Cash Flow-62,384.00-48,252.00-57,839.00-40,465.00-48,649.24-27,250.60-29,718.00-16,837.00-14,234.47-10,676.24
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-4.777.9-1.4
P/S032947.19.4
P/B3.45.15.2
P/FCF-5.13667.7-1.5
Market cap$0.7$20.8
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets18.3 %3 %0 %
Debt to Income-33.3 %-141.1 %0 %
Debt to Free cash flow-36.2 %-6353.6 %0 %
Interest expense percentage-3 %0.5 %44.7 %
Current ratio8.5 24.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-78.7 %-3.8 %0 %
ROA-54.9 %-28 %0 %
CapEx to Revenue0 %28911.8 %0 %
RaD to Revenue0 %79156.6 %0 %
ROEM0.0 32.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %-81 %68.7 %
Operating margin0 %-110510.8 %35.5 %
Net margin0 %-84697.6 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding63.4 mil 47.9 mil
Employee count0.1 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader